Novel Formulation of Ketorolac tromethamine for Controlled Release in Gastrointestinal and Colonic Delivery System
Andrade, J.R.; Maslanka, M.; Maneatis, T.; Bynum, L.; Burchomore, M. 1994. The use of ketorolac tromethamine in the management of post operative pain. Orthopedics, v. 17, p. 157–166.
Asghar, L.F.; Chure, C.B.; Chandran, S. 2009. Colon specific delivery of indomethacin: effect of incorporating ph sensitive polymers in xanthan gum matrix bases. AAPS Pharm Sci Tech., v. 10(2), p. 418-429.
Chopra, D.; Sinha, V.R.; Singh, M. 2008. Thermal and isothermal methods in development of sustained release dosage forms of ketorolac tromethamine. E-J Chem., v. 5(2), p. 316-322.
Chourasia, M.K.; Jain, S.K. 2003. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci., v. 6(1), p. 33-66.
Demiroz, F.T.; Acarturk, F.; Takka, S.; Boyunaga, O.K. 2004. In-vitro and In-vivo Evaluation of Mesalazine–Guar Gum Matrix Tablets for Colonic Drug Delivery. J Drug Targ, v. 12(2), p. 105–112.
Girish, N.P.; Gayatri, C.P.; Ritesh, B.P. 2006. Oral colon-specific drug delivery: an overview. Drug Delivery Tech., v. 6(7), p. 62-71.
Krishnaiah, Y.S.R.; Satyanarayana, S.; Ramaprasad, Y.V.; Narasimharao, S. 1998. Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm., v. 171, p. 137-146.
Mathews, B.R. 1999. Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm., v. 25, p. 831-856.
Mundargi, R.C.; Patil, S.A.; Agnihotri, S.A.; Aminabhavi, T.M. 2007. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis. Drug Dev Ind Pharm., v. 33, p. 255–264.
Robinson, J. R.; Lee, V. H. 1987. “Transdermal Therapeutic Systems” Charpter–12. in “ Control drug delivery,” 2nd edition V 29, p 523-531.
Shankar, C.; Mishra M. 2003. Development and in-vitro evaluation of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm., v. 53, p. 101–110.
aShyamala, B.; SANMATHI, B.S. 2001. Poly(lactic acid) microspheres of ketorolac tromethamine for parenteral controlled drug delivery system. Indian J Pharm Sci., v. 63, p. 538–540.
bshyamala, B.; Sanmathi, B.S. 2001. Innfluence of manufacturing parameters and the release profile of Ketorolac tromethamine from poly (Lactide-co-glycolide) microspheres. Indian Drugs, v. 38, p. 383–385.
Staniforth, J.N.; Aulton, M.E. Powder flow. In Aulton M. E. (Ed.) 2007. Aulton’s Pharmaceutics-The Design and Manufacture of Medicines. Churchill Livingstone: Elsevier, Inc. p. 168-179.
Uddin, M.N; Das, S.; Khan, S. H.; Shill, S. K.; Bhuiyan, H. R.; Karim, R. 2014. A novel validated UPLC method for the estimation of ketorolac tromethamine in pharmaceutical formulation. Research v. 1, p. 1237.
Valluru, R.; Siddaramaiah, T.; Pramod, M. 2008. Influence of natural polymer coating on novel colon targeting drug delivery system. J Mater Sci., v. 19, p. 2131–2136.
Vemula, S.K.; Veerareddy, P.R. 2009. Different approaches to design and evaluation of colon specific drug delivery systems. Int J Pharm Tech., v. 1(1), p. 1-35.
Vincent, H. L.; Suman, K. M. 2002. Drug delivery-oral colon-specific. In J. Swarbick and C. J. Boylan. (Ed.) Encyclopedia of Pharm Tech. New York: Marcel Dekker, Inc. p. 871-885.
Vyas, S.P.; Roop, K.K. 2006. Controlled drug delivery concepts and advances. 1st ed. Vallabh Prakashan Publishers, Delhi p. 218-256.
Wu, B.; Shun, N.; Wei, X.; Lu, Y.; Wu, W. 2007. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study. Eur J Pharm Biopharm., v. 67, p. 707–714.
- There are currently no refbacks.
Copyright (c) 2018 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:
View My Stats